Evaluation of dietary quality in patients with functional gastrointestinal symptoms: a Norwegian single centre study

  • Ida Marie Holm Department of Clinical Support, Lovisenberg Diaconal Hospital, Oslo, Norway
  • Sissi Christiane Stove Lorentzen Department of Clinical Support, Lovisenberg Diaconal Hospital, Oslo, Norway
  • Monica Hauger Carlsen Department of Nutrition, University of Oslo, Oslo, Norway
  • Jørgen Valeur Unger-Vetlesen Institute, Lovisenberg Diaconal Hospital, Oslo, Norway
  • Tonje Mellin-Olsen Department of Clinical Support, Lovisenberg Diaconal Hospital
  • Hanna Fjeldheim Dale Unger-Vetlesen Institute, Lovisenberg Diaconal Hospital, Oslo, Norway
Keywords: Nutritional evaluation, dietary patterns, irritable bowel syndrome, inflammatory bowel disease, Mediterranean diet, gut-microbiota interaction

Abstract

Background: Poor dietary quality has been described as a contributor to symptoms in subjects with functional gastrointestinal (GI) symptoms. Hitherto, the focus in dietary evaluation and treatment in this patient group has mainly been on avoiding individual nutrient deficiencies, and less attention has been given to the dietary pattern and the overall food quality. Hence, we aim to describe and evaluate the dietary quality in patients with functional GI symptoms.

Methods: Patients with GI symptoms and a diagnosis of irritable bowel syndrome or inflammatory bowel disease in remission, consecutively referred to a clinical dietitian for nutritional guidance, were included. All participants completed a 7-day weighed food record. The intake of foods, energy, macro- and micronutrients was computed. Dietary quality was evaluated by intake frequencies based on a predefined food index, combined with assessing achievement of nutrient intake recommendations.

Results: A total of 35 patients were included. Intake frequencies of red meat, cheese and sweets were high, whereas intake frequencies of green leafy vegetables, berries, nuts, whole grain and legumes were low. The total intake of vegetables, fruit, berries, fish and nuts was lower than current recommendations, and the intake corresponded to intake below recommendations for several micronutrients, including vitamins D, C and A; iodine; folate; potassium; and selenium.

Conclusion: The group of patients with GI symptoms had overall inadequate dietary quality. Low intake of nutrient-dense food groups considered as beneficial for health corresponded with insufficient intake of several micronutrients. We recommend that dietary evaluation should focus on the intake of food groups, rather than nutrients, in the treatment of patients with functional GI symptoms, to ensure a better evaluation of dietary quality.

Downloads

Download data is not yet available.

References


1.
Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130(5): 1480–91. doi: 10.1053/j.gastro.2005.11.061


2.
Fairbrass KM, Costantino SJ, Gracie DJ, Ford AC. Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2020; 5(12): 1053–62. doi: 10.1016/S2468-1253(20)30300-9


3.
García-Montero C, Fraile-Martínez O, Gómez-Lahoz AM, Pekarek L, Castellanos AJ, Noguerales-Fraguas F, et al. Nutritional components in western diet versus Mediterranean diet at the gut microbiota-immune system interplay. Implications for Health and Disease. Nutrients. 2021; 13(2): 699. doi: 10.3390/nu13020699


4.
Chicco F, Magrì S, Cingolani A, Paduano D, Pesenti M, Zara F, et al. Multidimensional impact of Mediterranean diet on IBD patients. Inflamm Bowel Dis. 2021; 27(1): 1–9. doi: 10.1093/ibd/izaa097


5.
Hillestad EMR, van der Meeren A, Nagaraja BH, Bjørsvik BR, Haleem N, Benitez-Paez A, et al. Gut bless you: the microbiota-gut-brain axis in irritable bowel syndrome. World J Gastroenterol 2022; 28(4): 412–31. doi: 10.3748/wjg.v28.i4.412


6.
Shau JP, Chen PH, Chan CF, Hsu YC, Wu TC, James FE, et al. Fast foods – are they a risk factor for functional gastrointestinal disorders? Asia Pac J Clin Nutr 2016; 25(2): 393–401. doi: 10.6133/apjcn.2016.25.2.28


7.
Tap J, Störsrud S, Le Nevé B, Cotillard A, Pons N, Doré J, et al. Diet and gut microbiome interactions of relevance for symptoms in irritable bowel syndrome. Microbiome 2021; 9(1): 74. doi: 10.1186/s40168-021-01018-9


8.
Buscail C, Sabate JM, Bouchoucha M, Kesse-Guyot E, Hercberg S, Benamouzig R, et al. Western dietary pattern is associated with irritable bowel syndrome in the French NutriNet cohort. Nutrients 2017; 9(9): 986. doi: 10.3390/nu9090986


9.
Rizzello F, Spisni E, Giovanardi E, Imbesi V, Salice M, Alvisi P, et al. Implications of the westernized diet in the onset and progression of IBD. Nutrients 2019; 11(5): 1033. doi: 10.3390/nu11051033


10.
Dale HF, Lorentzen SCS, Mellin-Olsen T, Valeur J. Diet-microbiota interaction in irritable bowel syndrome: looking beyond the low-FODMAP approach. Scand J Gastroenterol 2023; 58(12): 1366–77. doi: 10.1080/00365521.2023.2228955


11.
Paduano D, Cingolani A, Tanda E, Usai P. Effect of three diets (low-FODMAP, Gluten-free and Balanced) on irritable bowel syndrome symptoms and health-related quality of life. Nutrients 2019; 11(7): 1566. doi: 10.3390/nu11071566


12.
Staudacher HM, Mahoney S, Canale K, Opie RS, Loughman A, So D, et al. Clinical trial: a Mediterranean diet is feasible and improves gastrointestinal and psychological symptoms in irritable bowel syndrome. Aliment Pharmacol Ther 2024; 59(4): 492–503. doi: 10.1111/apt.17791


13.
National Institute for Health and Care Excellence. Clinical guidelines. Irritable bowel syndrome in adults: diagnosis and management. London: National Institute for Health and Care Excellence (UK) ; 2017.


14.
Slomski A. The low-FODMAP diet helps IBS symptoms, but questions remain. JAMA 2020; 323(11): 1029–31. doi: 10.1001/jama.2020.0691


15.
Ireton-Jones C, Weisberg MF. Management of irritable bowel syndrome: physician-dietitian collaboration. Nutr Clin Pract 2020; 35(5): 826–34. doi: 10.1002/ncp.10567


16.
Melchior C, Algera J, Colomier E, Törnblom H, Simrén M, Störsrud S. Food Avoidance and restriction in irritable bowel syndrome: relevance for symptoms, quality of life and nutrient intake. Clin Gastroenterol Hepatol 2022; 20(6): 1290–8.e4. doi: 10.1016/j.cgh.2021.07.004


17.
Limdi JK, Aggarwal D, McLaughlin JT. Dietary practices and beliefs in patients with inflammatory bowel disease. Inflamm Bowel Dis 2016; 22(1): 164–70. doi: 10.1097/MIB.0000000000000585


18.
Marsh A, Kinneally J, Robertson T, Lord A, Young A, Radford-Smith G. Food avoidance in outpatients with inflammatory bowel disease – who, what and why. Clin Nutr ESPEN 2019; 31: 10–16. doi: 10.1016/j.clnesp.2019.03.018


19.
de Castro MM, Corona LP, Pascoal LB, Miyamoto JÉ, Ignacio-Souza LM, de Lourdes Setsuko Ayrizono M, et al. Dietary patterns associated to clinical aspects in Crohn’s disease patients. Sci Rep 2020; 10(1): 7033. doi: 10.1038/s41598-020-64024-1


20.
Armet AM, Deehan EC, O’Sullivan AF, Mota JF, Field CJ, Prado CM, et al. Rethinking healthy eating in light of the gut microbiome. Cell Host Microbe 2022; 30(6): 764–85. doi: 10.1016/j.chom.2022.04.016


21.
Morris MC, Tangney CC, Wang Y, Sacks FM, Barnes LL, Bennett DA, et al. MIND diet slows cognitive decline with aging. Alzheimers Dement 2015; 11(9): 1015–22. doi: 10.1016/j.jalz.2015.04.011


22.
Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, et al. Bowel disorders. Gastroenterology 2016; 150(6): 1393–1407. doi: 10.1053/j.gastro.2016.02.031


23.
Miller V, Webb P, Micha R, Mozaffarian D. Defining diet quality: a synthesis of dietary quality metrics and their validity for the double burden of malnutrition. Lancet Planet Health 2020; 4(8): e352–70. doi: 10.1016/S2542-5196(20)30162-5


24.
Morris MC. Nutrition and risk of dementia: overview and methodological issues. Ann N Y Acad Sci 2016; 1367(1): 31–7. doi: 10.1111/nyas.13047


25.
Nasionalt råd for ernæring. Kostråd for å fremme folkehelsen og forebygge kroniske sykdommer: metodologi og vitenskapelig kunnskapsbidrag. Oslo: Helsedirektoratet; 2011.


26.
Hashash JG, Elkins J, Lewis JD, Binion DG. AGA clinical practice update on diet and ntritional therapies in patients with inflammatory bowel disease: expert review. Gastroenterology 2024; 166(3): 521–32. doi: 10.1053/j.gastro.2023.11.303


27.
Nouri-Majd S, Salari-Moghaddam A, Hassanzadeh Keshteli A, Esmaillzadeh A, Adibi P. The association between adherence to the MIND diet and irritable bowel syndrome. Dig Dis 2022; 40(2): 198–205. doi: 10.1159/000517015


28.
Wu S, Yang Z, Liu S, Zhang Q, Zhang S, Zhu S. Ultra-processed food consumption and long-term risk of irritable bowel syndrome: a large-scale prospective cohort study. Clin Gastroenterol Hepatol 2024; 7: 1497–1507.e5. doi: 10.1016/j.cgh.2024.01.040


29.
Monteiro CA, Cannon G, Lawrence M, Costa Louzada ML, Pereira Machado P. Ultra-processed foods, diet quality, and health using the NOVA classification system. Rome: Food and Agriculture Organization of the United Nations.; 2019.


30.
Zerouga I. Master thesis: dietary and FODMAP intake in newly diagnosed inflammatory bowel disease patients and associations with irritable bowel syndrome. Oslo, Norway: University of Oslo; 2021.


31.
Zerouga I, Valeur J, Sommer C, Cvancarova Småstuen M, Medhus AW, Lund C, et al. Dietary intake and nutritional status in patients with newly diagnosed inflammatory bowel disease: insights from the IBSEN III study. Scand J Gastroenterol. 2024; 15: 1–9. doi: 10.1080/00365521.2024.2313056


32.
Bouzid YY, Wilson SM, Alkan Z, Stephensen CB, Lemay DG. Lower diet quality associated with subclinical gastrointestinal inflammation in healthy United States adults. J Nutr 2024; 154(4): 1449–60. doi: 10.1016/j.tjnut.2024.02.030


33.
Totland TH, Melnæs BK, Lundberg-Hallén N, Hellan-Kigen KM, Lund-Blix NA, Myhre JB, et al. Norkost 3: En landsomfattende kostholdsundersøkelse blant menn og kvinner i Norge i alderen 18–70 år, 2010–2011. Oslo: Helsedirektoratet; 2012.


34.
Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 2014; 146(1): 67–75.e5. doi: 10.1053/j.gastro.2013.09.046


35.
Hillestad EMR, Van Der Meeren A, Nagaraja BH, Bjørsvik BR, Haleem N, Benitez-Paez A, et al. Gut bless you: the microbiota-gut-brain axis in irritable bowel syndrome. World J Gastroenterol 2022; 28(4): 412–31. doi: 10.3748/wjg.v28.i4.412


36.
Simrén M, Tack J. New treatments and therapeutic targets for IBS and other functional bowel disorders. Nat Rev Gastroenterol Hepatol 2018; 15(10): 589–605. doi: 10.1038/s41575-018-0034-5


37.
Willett W. Nutritional epidemiology. 3rd ed. Boston, USA: Oxford University Press; 2013.


38.
FAO. Dietary assessment: a resource guide to method selection and application in low resource settings. Rome: Food and Agriculture Organization of the United Nations; 2018.


39.
Lane MM, Gamage E, Du S, Ashtree DN, McGuinness AJ, Gauci S, et al. Ultra-processed food exposure and adverse health outcomes: umbrella review of epidemiological meta-analyses. BMJ 2024; 384: e077310. doi: 10.1136/bmj-2023-077310
Published
2024-12-23
How to Cite
Holm I. M., Lorentzen S. C. S., Hauger Carlsen M., Valeur J., Mellin-Olsen T., & Dale H. F. (2024). Evaluation of dietary quality in patients with functional gastrointestinal symptoms: a Norwegian single centre study. Food & Nutrition Research, 68. https://doi.org/10.29219/fnr.v68.10692
Section
Original Articles